中路高科交通检测检验认证有限公司武汉分公司

基石药业（苏州）有限公司

CStone Pharmaceuticals is an innovative, research-driven biopharmaceutical enterprise dedicated to pioneering the development of cutting-edge therapeutic medications. Situated in both Shanghai and Suzhou, the company boasts a leadership team comprised of experienced executives from leading multinational pharmaceutical corporations. In July 2016, CStone disclosed the successful conclusion of its Series A funding round, securing a total investment of $150 million (approximately 975 million RMB). This round was co-invested by three prominent industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).

With an unwavering commitment to addressing the critical healthcare needs of Chinese patients, CStone's extensive pipeline encompasses five therapeutic areas: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune disorders. The company's strategic focus on immuno-oncology serves as its cornerstone, aiming to propel Chinese research onto the global stage through its world-class research and development capabilities, an innovative drug portfolio, and an open innovation approach.

CStone Pharmaceuticals is a pioneering, research-focused biopharmaceutical company headquartered in Shanghai and Suzhou, China. Its executive team comprises seasoned professionals from top-tier multinational pharmaceutical firms. In July 2016, the company successfully concluded its Series A funding round, attracting a total investment of $150 million (equivalent to approximately 975 million RMB). This round was jointly supported by three distinguished industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).

Driven by a mission to meet the pressing medical needs of Chinese patients, CStone's comprehensive product pipeline spans across five therapeutic sectors: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune diseases. With immuno-oncology at the heart of its strategic focus, the company aspires to position Chinese research on the global stage, leveraging its world-class research and development expertise, innovative drug portfolio, and an open innovation philosophy.

蚂蚁教育

秦皇岛市海港区蚂蚁建筑职业技能培训学校一直致力于为企业和再就业人员提供专业培训及建筑企业资质申报等咨询服务，为全国输送大批专业技术人才。作为一家集职业教育与网络教育于一体的综合教育产品研发机构，该校坚持以质量求生存，以特色求发展，以市场需求为导向，以用户满意为目标；以推动个人、企业与社会的和谐发展为使命，与时俱进，共创辉煌。秉持诚实守信、客户至上的服务理念，坚持一切为了学员、让学员满意的一切办学宗旨，秉承“善之本在教，教之本在师”的核心理念。

贵州酱怀天下酒业有限公司

公司的服务愿景是颠覆传统酒水营销模式，将酒水销售、互联网和移动智能通信终端三者有机结合。利用互联网和智能终端设备，构建线上线下一体化服务体系，为消费者提供信息、采购、顾客、物流数字化的快乐消费体验。

创造财富，这是永恒的话题。通过向客户提供专业高效的服务，最大化其利益。我们致力于优化酒类销售模式，为客户创造价值，提升行业操作和服务水准，提高资源集成度，传承酒类文化。

推动发展，现状永不值得满足，因明天充满机遇与挑战。我们致力于不断创新，以高标准服务赢得信任与尊重，推动市场和行业发展。具备前瞻性战略眼光和创新开发理念，不断开拓酒类销售新路径。

成就事业，我们不仅收获物质满足，还有广阔发展空间、伙伴情谊、创造性工作氛围及社会认可与尊重。它赋予我们的不仅是满足与乐趣，更是共同事业的成就。

威特晟

深圳市威特晟科技有限公司自2011年成立以来，始终专注于焊割类产品的研发、生产、销售与服务。产品涵盖手工焊、氩弧焊、半自动气保焊、等离子切割机及激光焊等多种设备，广泛应用于日常维修、不锈钢与铝制品制造、工业制造以及家私和厨具等行业。公司明确响应国家“一带一路”倡议，产品主要出口至俄罗斯、印度、泰国、马来西亚、巴西等国家。

随着业务迅速扩展与稳步发展，威特晟科技（河源）有限公司于2020年在河源东源盐东物流园启动新生产基地建设，并于2022年实现试产；2024年，凭借专业技术能力和卓越市场表现，威特晟科技（河源）有限公司荣获专精特新中小企业及国家级高新技术企业称号，这是对过往成就的认可，也是对未来发展的激励。展望未来，威特晟将坚持专业、创新、务实、高效的企业精神，持续提升产品质量与服务水平，为客户提供更优的焊割设备解决方案，助力行业发展。

沃霖（深圳）实业投资咨询有限公司

沃霖（深圳）实业投资咨询有限公司，公司规模少于50人，公司类型民营公司，所属行业金融/投资/证券。